Cited by 215Computational Drug Discovery MethodsMachine Learning in Materials SciencePharmacogenetics and Drug Metabolism

Bayer’s in silico ADMET platform: a journey of machine learning over the past two decades

Open access
Göller, Andreas H., Kuhnke, Lara, Montanari, Floriane, Bonin, Anne, Schneckener, Sebastian, ter Laak, Antonius, Wichard, Jörg, Lobell, Mario +1 more·2020·Drug Discovery Today

Abstract

Over the past two decades, an in silico absorption, distribution, metabolism, and excretion (ADMET) platform has been created at Bayer Pharma with the goal to generate models for a variety of pharmacokinetic and physicochemical endpoints in early drug discovery. These tools are accessible to all scientists within the company and can be a useful in assisting with the selection and design of novel leads, as well as the process of lead optimization. Here. we discuss the development of machine-learning (ML) approaches with special emphasis on data, descriptors, and algorithms. We show that high company internal data quality and tailored descriptors, as well as a thorough understanding of the experimental endpoints, are essential to the utility of our models. We discuss the recent impact of deep neural networks and show selected application examples.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.drudis.2020.07.001

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Recent lessons shared by scientists at AstraZeneca, Bayer, Merck and GSK highlight the complexities of ADMET property prediction.

    “Recent lessons shared by scientists at AstraZeneca (83), Bayer (84), Merck (85) and GSK (86) highlight the complexities of ADMET property prediction (87).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Ramsundar, B.L. et al. (2019) Deep Learning for the Life Sciences: Applying Deep Learning to Genomics, Microscopy, Drug Discovery, and More. O'Reilly Media 27

Cited by

Sorted by citations

Authors
Göller, A. H., Kuhnke, L., Montanari, F., Bonin, A., Schneckener, S., ter Laak, A., Wichard, J., Lobell, M., & Hillisch, A.
Affiliations
Bayer (Germany) (DE)
Corresponding author
Hillisch, Alexander
Venue
Drug Discovery Today
Publisher
Elsevier BV
Published
2020-09
Volume
25
Issue
9
Pages
1702-1709
ISSN
1359-6446 (ISSN-L)
OpenAlex
W3041286284
Cited by
215
References
62
Citations by year
2026: 22 · 2025: 38 · 2024: 56 · 2023: 38 · 2022: 30 · 2021: 27 · 2020: 3
FWCI
2.18
Type
journal article
Language
en
Open access
Locations
  • Drug Discovery Today (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Topics
  • Physical Sciences › Computer Science › Computational Theory and Mathematics › Computational Drug Discovery Methods
  • Physical Sciences › Materials Science › Materials Chemistry › Machine Learning in Materials Science
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
Keywords
machine learning, pharmacokinetic prediction, physicochemical properties, early drug discovery, deep neural network, molecular descriptors, lead optimization
MeSH terms
Machine Learning, Animals, Computer Simulation, Pharmaceutical Preparations, Humans, Intestinal Absorption, Models, Theoretical, Pharmacokinetics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review